| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-10 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-09 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-09 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
6e-08 |